Novartis: "Ready new investments "
Siena, February 18, 2010 - unions against Novartis . avviatosi A clash after putting on the move of 24 employees of the fund's largest holding of commercial vaccines which now adds them to the concerns of the union to maintain the current level of employment. And so, groped to be peacemaker we feel with the institutions at the forefront of the provincial administration, which last week held a table institutions, trade unions if they so request, for a comparison with the company Novartis.
invited comparison to the representatives of the towns of Siena and Sovicille, Confindustria, the unions, the RSU of Novartis, the pharmaceutical company executives and the chairman of the Region of Tuscany, Claudio Martini. An important presence in the latter emphasize the importance of a company that represents a significant asset beyond the provincial border. The leadership of Novartis demonstrates the evolution of the employment trends of recent years and said they were ready to continue with investments in the sites of Siena and Rosia. "We went from 1080 to 1471 permanent employees - said Gianluca Magnani, head of Novartis staff - with around 2,300 people working for us. In addition to the 400 million already invested in two factories in Siena and Rosia, there are a whole series investment under discussion that could have more positive effects for Siena and its province. Some concerns of trade unions are too: for example, I can assure you that we will continue to have the production of vaccination season. "
It looks like the same view, the secretary of the CGIL Siena Claudio Vigni " The positive part of the meeting was that the support of local institutions and the region that gave us an important availability. Less positive the part for Novartis, the company is unable to say what will be the investments beyond 2010. There is a short term vision that keeps us alert, ask for precise answers. For example, on assumptions made for the Pandemic: 400 people on short term contracts that if they are not renewed will to create a surplus difficult to replace. We have ensured that will not move until 2012 the production of flu vaccine, but a possible transfer abroad can lead to additional effects negative. The company also reiterated that for permanent employees is not a problem, but for the other 800 workers? ".
to echo him Gian Luca Fè CISL :" We have raised our perplexity, from the perspectives for the next two or three years that are fairly nebulous. They are pursuing the development of some quality products, such as the vaccine against meningitis, but it will not be ready until 2012: to date there are doubts about the renewal of temporary contracts and the consolidation of employment. A worry about the mobility of these 24 workers: innanzittuo for their personal destiny but also that of the commercial company that we consider of crucial importance. "institutions, on their par, stressed the need to elevate the quality of the relationships between the company and unions and reiterated their determination to continue to monitor the situation regarding the maintenance of employment levels and trajectories of development of the corporation.
0 comments:
Post a Comment